Cite
Exosomal miR‐21‐5p derived from multiple myeloma cells promote renal epithelial–mesenchymal transition through targeting TGF‐β/SMAD7 signalling pathway.
MLA
Liu, Liping, et al. “Exosomal MiR‐21‐5p Derived from Multiple Myeloma Cells Promote Renal Epithelial–mesenchymal Transition through Targeting TGF‐β/SMAD7 Signalling Pathway.” Clinical & Experimental Pharmacology & Physiology, vol. 50, no. 9, Sept. 2023, pp. 711–18. EBSCOhost, https://doi.org/10.1111/1440-1681.13768.
APA
Liu, L., Liu, L., Liu, R., Liu, J., & Cheng, Q. (2023). Exosomal miR‐21‐5p derived from multiple myeloma cells promote renal epithelial–mesenchymal transition through targeting TGF‐β/SMAD7 signalling pathway. Clinical & Experimental Pharmacology & Physiology, 50(9), 711–718. https://doi.org/10.1111/1440-1681.13768
Chicago
Liu, Liping, Langni Liu, Rui Liu, Jing Liu, and Qian Cheng. 2023. “Exosomal MiR‐21‐5p Derived from Multiple Myeloma Cells Promote Renal Epithelial–mesenchymal Transition through Targeting TGF‐β/SMAD7 Signalling Pathway.” Clinical & Experimental Pharmacology & Physiology 50 (9): 711–18. doi:10.1111/1440-1681.13768.